FDA declines to approve Pain Therapeutics’ opioid drug, shares plunge
By Manas Mishra and Ashwin Shyam (Reuters) – The U.S. Food and Drug Administration declined to approve Pain Therapeutics Inc’s abuse-deterrent opioid treatment Remoxy for the fourth time, sending the company’s...
Read More